These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 18854957)

  • 1. The influence of sphingosine-1-phosphate receptor signaling on lymphocyte trafficking: how a bioactive lipid mediator grew up from an "immature" vascular maturation factor to a "mature" mediator of lymphocyte behavior and function.
    Davis MD; Kehrl JH
    Immunol Res; 2009; 43(1-3):187-97. PubMed ID: 18854957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the lysophospholipid sphingosine 1-phosphate in immune cell biology.
    von Wenckstern H; Zimmermann K; Kleuser B
    Arch Immunol Ther Exp (Warsz); 2006; 54(4):239-51. PubMed ID: 16830220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes exit lymph nodes through cortical lymphatic sinusoids by a mechanism independent of sphingosine-1-phosphate-mediated chemotaxis.
    Sinha RK; Park C; Hwang IY; Davis MD; Kehrl JH
    Immunity; 2009 Mar; 30(3):434-46. PubMed ID: 19230723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of sphingosine 1-phosphate on functions of T cell - review].
    Huang WR; Wang LS; DA WM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics.
    Ledgerwood LG; Lal G; Zhang N; Garin A; Esses SJ; Ginhoux F; Merad M; Peche H; Lira SA; Ding Y; Yang Y; He X; Schuchman EH; Allende ML; Ochando JC; Bromberg JS
    Nat Immunol; 2008 Jan; 9(1):42-53. PubMed ID: 18037890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production.
    Kunisawa J; Kurashima Y; Gohda M; Higuchi M; Ishikawa I; Miura F; Ogahara I; Kiyono H
    Blood; 2007 May; 109(9):3749-56. PubMed ID: 17234743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension.
    Meissner A; Miro F; Jiménez-Altayó F; Jurado A; Vila E; Planas AM
    Cardiovasc Res; 2017 Feb; 113(2):123-133. PubMed ID: 28082452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced FTY720-mediated lymphocyte homing requires G alpha i signaling and depends on beta 2 and beta 7 integrin.
    Pabst O; Herbrand H; Willenzon S; Worbs T; Schippers A; Müller W; Bernhardt G; Förster R
    J Immunol; 2006 Feb; 176(3):1474-80. PubMed ID: 16424175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
    Kihara A; Igarashi Y
    Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
    Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
    Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes.
    Singer II; Tian M; Wickham LA; Lin J; Matheravidathu SS; Forrest MJ; Mandala S; Quackenbush EJ
    J Immunol; 2005 Dec; 175(11):7151-61. PubMed ID: 16301618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
    Chiba K; Matsuyuki H; Maeda Y; Sugahara K
    Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-phosphate in coagulation and inflammation.
    Obinata H; Hla T
    Semin Immunopathol; 2012 Jan; 34(1):73-91. PubMed ID: 21805322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo.
    Lan YY; De Creus A; Colvin BL; Abe M; Brinkmann V; Coates PT; Thomson AW
    Am J Transplant; 2005 Nov; 5(11):2649-59. PubMed ID: 16212624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis.
    Mehling M; Johnson TA; Antel J; Kappos L; Bar-Or A
    Neurology; 2011 Feb; 76(8 Suppl 3):S20-7. PubMed ID: 21339487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y; Seki N; Sato N; Sugahara K; Chiba K
    Int Immunol; 2010 Jun; 22(6):515-25. PubMed ID: 20497959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R⁻/⁻) mice.
    Poti F; Costa S; Bergonzini V; Galletti M; Pignatti E; Weber C; Simoni M; Nofer JR
    Vascul Pharmacol; 2012 Aug; 57(1):56-64. PubMed ID: 22459073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
    Chiba K
    Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression.
    Brinkmann V; Chen S; Feng L; Pinschewer D; Nikolova Z; Hof R
    Transplant Proc; 2001; 33(1-2):530-1. PubMed ID: 11266942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.